New South San Francisco Location Offers CleanSuites, Broadening Scope of Lab Capabilities to Span Early-Stage R&D through Product Commericialization 

Entrada Therapeutics accelerates its R&D and achieves significant growth by leveraging SmartLabs' flexible infrastructure, customized labs, and wraparound services, enabling them to rapidly advance research, attract top talent, and secure substantial funding. Read more about their success story here.

Discover how SmartLabs empowers Scorpion Therapeutics, an emerging biotech startup in oncology, through high-quality support, rapid access to top-notch infrastructure, and a collaborative partnership, fueling groundbreaking research and driving remarkable strides in cancer treatment—Read more.

Witness how SmartLabs propelled Gritstone Bio's groundbreaking achievements in biotechnology, providing essential space, state-of-the-art facilities, and a competitive edge—Read more to delve into their accelerated progress and partnership driving scientific innovation and medical breakthroughs

Embark on a captivating journey where SmartLabs revolutionizes Cue Biopharma's drug development, breaking boundaries and transforming lives—Discover the limitless possibilities and the future of medicine powered by SmartLabs, and prepare to be inspired—Read more.

Explore how SmartLabs accelerated Sana Biotechnology's rapid launch of innovative R&D programs, providing advanced resources and unwavering support for exponential growth—Read more to witness their dynamic partnership and groundbreaking advancements in biotechnology.

East Cambridge site establishes the largest network of novel modality development and bioproduction capacities by any organization in the world and expands company’s Greater Boston footprint by 75%.

SmartLabs CEO, Amrit Chaudhuri, was interviewed by Fierce Biotech during 2023 JPM Week. Tune in to hear Amrit discuss the biggest challenges in the biotech industry, and how SmartLabs is tackling them. 

SmartLabs CEO, Amrit Chaudhuri, was recently interviewed by Executive Platforms during the 2022 Biomanufacturing World Summit. Listen in as Amrit discusses issues and trends in the biopharma industry and where SmartLabs plays an integral role in providing a solution for therapeutic companies!

The Cell, Gene, & Immunotherapy event is for manufacturing efficiencies, cost, and quality. 

Accelerate your bioprocessing, analytics, supply chain security and commercialization strategies by accessing novel science, technologies and the contacts you need

For more than 10 years, The Bioprocessing Summit has been recognized as the premier forum for industry leaders to share the latest research in bioprocess R&D, scale-up, quality and analytics.

Recently, Biopharma and Life Science companies are facing dramatic devaluations which have made a negative impact on private funding and have left growing companies navigating a series of complex decisions as their business grows. 

Listen in as SmartLabs Co-Founder/CBO, Seth Taylor, moderates a discussion with Todd Foley, Managing Director of MPM Capital, and Chad Cowen, CEO of Clade Therapeutics, on the current market and its implications for growing companies.